NCT02208102View on ClinicalTrials.gov

Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

CompletedOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2016

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Radio-frequency catheter ablation

Trial Locations (1)

78727

Texas Cardiac Arrhythmia Institute, St. david's Medical Center, Austin

All Listed Sponsors
lead

Texas Cardiac Arrhythmia Research Foundation

OTHER

NCT02208102 - Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation | Biotech Hunter | Biotech Hunter